Related Experiment Video
Updated: Aug 14, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Nosocomial pneumonia, including ventilator-associated pneumonia
1Pulmonary and Critical Care Division, Department of Medicine, Northwestern University Feinberg School of Medicine, 676 North St Clair, Suite 14-044, Chicago, IL 60611, USA. r-wunderink@northwestern.edu
Nosocomial pneumonia patients exhibit immunosuppression, increasing infection risk. Temporary immunoparalysis and genetic factors contribute, necessitating prompt infection treatment and immunomodulatory therapies.
Area of Science:
- Immunology
- Infectious Diseases
- Critical Care Medicine
Background:
- Patients with nosocomial pneumonia often show signs of immunosuppression.
- Endotracheal intubation compromises mechanical barriers, but only a subset of ventilated patients develop pneumonia, indicating broader immune alterations.
- This immune compromise is linked to an increased incidence of multiple, sequential infections.
Purpose of the Study:
- To investigate the mechanisms behind immunosuppression in patients with nosocomial pneumonia.
- To explore the roles of temporary immunoparalysis and genetic predisposition in the development of these infections.
- To identify potential therapeutic strategies for mitigating infection risk.
Main Methods:
- Review of existing literature on immune defects in nosocomial pneumonia.
- Analysis of factors contributing to immunosuppression, including mechanical ventilation and genetic polymorphisms.
- Examination of the impact of infection treatment and immunomodulatory therapies on immune status.
Main Results:
- A temporary state of immunoparalysis occurs in these patients, significantly increasing infection risk.
- Genetic polymorphisms in immune mediators and pathogen recognition molecules are associated with increased risk and severity of nosocomial infections.
- Reversal of temporary immunoparalysis is achievable through adequate initial infection treatment and specific immunomodulatory therapies.
Conclusions:
- Both temporary immunoparalysis and a genetically predisposed subpopulation contribute to the clinical presentation of nosocomial pneumonia.
- Understanding these immune mechanisms is crucial for developing effective prevention and treatment strategies.
- Targeted therapies can potentially reverse immune deficits and reduce the incidence of nosocomial infections.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Atypical Pneumonia
Pneumonia III: Complications and Assessment
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation (NIPPV)
